Final answer:
Healthcare providers must disclose events that result in harm to patients. Adverse drug events must be reported promptly. Post-marketing surveillance is vital for monitoring drug safety.
Explanation:
An event must be disclosed to the patient and/or representative if it resulted in permanent patient harm or near death. Disclosure is essential for transparency and accountability in healthcare.
Healthcare providers are required by law to notify patients and authorities of any serious adverse drug events within specific timeframes.
Post-marketing surveillance plays a crucial role in monitoring adverse drug reactions and ensuring drug safety in the long term.
Learn more about Patient safety and disclosure here:
https://brainly.com/question/43166295
